Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer
Authors
Keywords
Docetaxel, Paclitaxel, Peripheral neuropathy, Breast cancer, Treatment
Journal
SUPPORTIVE CARE IN CANCER
Volume 25, Issue 7, Pages 2241-2248
Publisher
Springer Nature
Online
2017-02-16
DOI
10.1007/s00520-017-3631-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCCN Task Force Report: Management of Neuropathy in Cancer
- (2017) Michael D. Stubblefield et al. Journal of the National Comprehensive Cancer Network
- Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
- (2016) Ting Bao et al. BREAST CANCER RESEARCH AND TREATMENT
- Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
- (2015) Edgardo Rivera et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199
- (2015) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors
- (2015) L. Eckhoff et al. EUROPEAN JOURNAL OF CANCER
- Can pregabalin prevent paclitaxel-associated neuropathy?—An ACCRU pilot trial
- (2015) Shivani S. Shinde et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-induced neuropathy: A comprehensive survey
- (2014) N.C. Miltenburg et al. CANCER TREATMENT REVIEWS
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience
- (2014) Bhavana Bhatnagar et al. SpringerPlus
- Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
- (2014) Andreas Argyriou et al. Cancer Management and Research
- Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer
- (2013) L. Eckhoff et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
- (2013) Ellen M. Lavoie Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer
- (2012) Bryan P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation
- (2012) Karima Osmani et al. JOURNAL OF NEUROLOGY
- Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial
- (2012) Kojiro Shimozuma et al. SUPPORTIVE CARE IN CANCER
- Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis
- (2009) Davide Mauri et al. CANCER TREATMENT REVIEWS
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
- (2009) Kojiro Shimozuma et al. SUPPORTIVE CARE IN CANCER
- Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy
- (2008) Ravi D. Rao et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search